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A 49-year-old man with hypertension, diabetes, 
and chronic renal failure on dialysis was treated 
with cardiac surgery involving coronary bypass 
and Medtronic Mosaic bioprosthetic mitral 
valve (MV) replacement for MRSA infective 
endocarditis (IE) at another institution. He 
presented a month later with decompensated 
heart failure due to severe paravalvular mitral 
regurgitation with hemolytic anemia. 
Transthoracic echocardiography (TTE) 
demonstrated a focal echodensity on the ven-
tricular side of the MV prosthesis (Figure 1A, 
arrow). Blood cultures were negative and there 
were no systemic features of sepsis. Transesoph-
ageal echocardiography (TEE) clarified that the 
echodensity was actually a distorted prosthetic 
valve strut, which was seemingly bent around 
outside of the annulus and protruding into the 
left atrium (Figure 1B–C, arrows). This was creat-
ing two paravalvular leaks (PVL) (posteromedi-
ally at 5 o’clock and posterolaterally at 8 o’clock 
in the surgeon’s view), which in combination 
resulted in severe mitral regurgitation (Figure 
1D, arrows). There were no clinical or echocar-
diographic findings to suggest IE. 
The hospital course was complicated by 
the hemorrhagic shock which required embo-
lization of the right inferior segmental renal 
artery and midzone interlobar artery. Due to his 
comorbidities, the patient was felt to be a high-
risk redo surgical candidate. He, therefore, 
underwent percutaneous PVL closure (PVLC) 
under conscious sedation. 3D TEE was essential 
for guidance of this procedure, which required 
the deployment of six closure devices around 
the posterior aspect of the prosthetic valve an-
nulus (Figure 1E, arrow) to successfully reduce 
the regurgitation to mild. Hemolytic anemia 
resolved following the procedure.
Three months later the patient presented 
with MRSA septic shock likely due to an infect-
ed dialysis catheter. TTE and TEE confirmed 
good PVLC results and revealed a decrease in 
left ventricular ejection fraction from 60% to 
30% without findings suggestive of IE. Cardiac 
computed tomography (CT) revealed a fluid 
collection in the anterior chest wall. Radiola-
belled white blood cell single-photon emission 
CT(SPECT)/CT found an abnormal uptake 
within the anterior chest wall confirming the 
presence of a sternal abscess and nonspecific 
uptake in the MV (Figure 1F, arrow). Sternal 
wound debridement was performed. The deci-
sion was made to defer MV replacement due to 
high surgical risk, negative blood cultures, and 
lack of definite IE diagnosis and IE complications 
on imaging studies. Follow-up TTE revealed an 
interval increase in LVEF to 55%.
The incidence of PVL after surgical valve 
replacement is 2%–10% in the aortic position 
and 7%–17% in the mitral position [1, 2]. 1%–5% 
of PVL cause serious clinical complications 
including hemolytic anemia, heart failure, and 
IE [1, 2]. 3D TEE is the gold standard for PVL 
evaluation [1]. PVLC is a safe and less invasive al-
ternative to surgical reintervention for patients 
who are deemed unsuitable for surgery  [2]. 
PVLC is associated with a high success rate and 
lower morbidity and mortality [1, 2]. Active IE is 
a contraindication to PVLC, although the diag-
nosis of prosthetic valve IE is often challenging 
[3]. Radiolabelled white blood cell SPECT/CT 
increases the specificity of the modified Duke 
criteria in prosthetic valve IE, especially in the 
case of recent cardiac surgery and foreign body 
implantation, although the uptake in this pa-
tient was nonspecific, and there were no other 
findings to suggest IE [4].
886
K A R D I O L O G I A  P O L S K A ,  2 0 2 1 ;  7 9  ( 7 – 8 )
w w w . j o u r n a l s . v i a m e d i c a . p l / k a r d i o l o g i a _ p o l s k a
Article information
Conflict of interest: None declared.
Open access: This article is available in open access under Creative 
Common Attribution-Non-Commercial-No Derivatives 4.0 Interna-
tional (CC BY-NC-ND 4.0) license, allowing to download articles and 
share them with others as long as they credit the authors and the 
publisher, but without permission to change them in any way or use 
them commercially. For commercial use, please contact the journal 
office at kardiologiapolska@ptkardio.pl.
How to cite: Gil KE, Jellis C, Krishnaswamy A. Challenging mitral par-
avalvular leak and recurrent infective endocarditis. Kardiol Pol. 2021; 
79(7–8): 885–886, doi: 10.33963/KP.a2021.0016.
Figure 1. Percutaneous paravalvular leak closure. A. Transthoracic echocardiographic three-chamber view revealing a focal echodensity 
on the left-ventricular side of the mitral valve prosthesis concerning vegetation or thrombus (arrow). B. and C. 2D and 3D transesophageal 
echocardiographic views showing a bent prosthetic valve strut (arrows). D. Resultant severe paravalvular mitral regurgitation (arrows). E. Final 
result of percutaneous paravalvular leak closure with six closure devices under 3D transesophageal echocardiography guidance (arrows). 
F. Radiolabelled white blood cell SPECT/CT scan revealing abnormal uptake within the anterior chest wall and nonspecific focal uptake along 
with the prosthetic mitral valve (arrows)
Abbreviations: CT, computed tomography; SPECT, single-photon emission CT
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